Narayana Hrudayalaya Limited’s Board of Directors approved the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. The Board meeting concluded on February 13, 2026. The results package includes the Limited Review Report. Key standalone financial indicators show the Net Profit Margin for Q3 FY2026 at 7.82%, an increase from the previous quarter. The company also noted an exceptional item related to the impact of new Labour Codes.
Board Approval of Financial Performance for Q3 FY2026
Narayana Hrudayalaya Limited announced the outcome of its Board meeting held on Friday, February 13, 2026. The Board formally approved the Unaudited Standalone and Consolidated Financial Results for the quarter and the nine months ended December 31, 2025, following a review by the Audit Committee. The meeting commenced at 03:30 P.M. IST and concluded at 06:00 P.M. IST.
Standalone Financial Highlights (Q3 FY2026 vs. Q2 FY2026)
Analysis of the standalone results reveals several key movements:
- Total Income: Decreased to ₹9,846.32 million in Q3 FY2026 from ₹10,362.57 million in the preceding quarter.
- EBITDA: Stood at ₹2,206.15 million for the quarter ending December 31, 2025.
- Net Profit: The Net Profit for the quarter was ₹757.37 million.
- Net Profit Margin (%): Reported at 7.82% for the quarter, compared to 13.53% in Q2 FY2026.
- Operating Margin (%): Recorded at 21.14% for Q3 FY2025.
Standalone Exceptional Items
The company recorded an Exceptional Item (Note 7) of (₹452.76 million). This relates to the financial implications assessed due to the Government of India notifying the Labour Codes in November 2025, resulting in an increase in gratuity and leave liability arising from past service costs.
Consolidated Performance Snapshot
The consolidated results, reflecting the Group’s performance, show:
- Consolidated Revenue from Operations (Q3 FY2026): Totaled ₹21,826.79 million, up from ₹17,073.01 million in the prior year’s corresponding quarter.
- Consolidated Profit After Tax (Q3 FY2026): Attributable profit to the company was ₹1,560.67 million.
- Consolidated Net Profit Margin (%): Stood at 5.95% for the quarter ended December 31, 2025.
Consolidated Exceptional Items and M&A Updates
Consolidated results include an Exceptional Item of (₹509.36 million), primarily due to the assessment of the Labour Codes impact on the Group.
Several corporate activities were noted, including the ongoing Scheme of Arrangement for the merger of Meridian Medical Research & Hospital Ltd. (MMRHL), which was filed with the NCLT on September 27, 2025, and the approved Scheme of Arrangement involving NH Integrated Care Private Limited (NHIC), filed on December 17, 2025.
Furthermore, the acquisition of Practice Plus Group Hospitals Limited (PPG UK) was completed on November 6, 2025, which impacts comparability with prior periods.
Post-Period Development
Subsequent to the reporting period, on January 16, 2026, the Group incorporated a wholly owned subsidiary, Narayana Healthcare North Private Limited (NHNPL), to expand healthcare services operations.
Source: BSE
